Literature DB >> 20368698

The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.

Peter Fickert1, Andrea Thueringer, Tarek Moustafa, Dagmar Silbert, Judith Gumhold, Oleksiy Tsybrovskyy, Margitta Lebofsky, Hartmut Jaeschke, Helmut Denk, Michael Trauner.   

Abstract

Proinflammatory and profibrotic cytokines such as osteopontin (OPN) and tumor necrosis factor-alpha receptor-1 (TNFR(1)) may be critically involved in the pathogenesis of cholangiopathies and biliary fibrosis. We therefore aimed to determine the role of genetic loss of either OPN or TNFR(1) in 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-fed mice as a model of xenobiotic-induced sclerosing cholangitis with biliary-type liver fibrosis using respective knock-out mice. OPN and TNFR(1) knock-out mice were fed a 0.1% DDC-supplemented diet for 4 weeks and compared with corresponding wild-type (WT) controls. Liver morphology (H&E staining), serum markers of liver injury and cholestasis (ALT, AP, bilirubin), markers of inflammation in liver (CD11b and F4/80 immunostaining, mRNA expression of iNOS, MCP-1, IL-1beta, INF-gamma, TNF-alpha and OPN), degree of ductular reaction (immunohistochemistry with morphometric analysis and western blotting for cholangiocyte-specific marker keratin 19) and degree of liver fibrosis (Sirius-red staining, hepatic hydroxyproline content for quantification) were compared between groups. DDC feeding in OPN and TNFR(1) knock-out mice and respective WT controls resulted in comparable extent of liver injury, inflammatory response, ductular reaction and liver fibrosis. Our data indicate that genetic loss of neither OPN nor TNFR(1) significantly effects on the pathogenesis of DDC-induced sclerosing cholangitis, ductular reaction and resulting biliary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368698      PMCID: PMC4285781          DOI: 10.1038/labinvest.2010.61

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  51 in total

1.  Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts.

Authors:  J You; G C Reilly; X Zhen; C E Yellowley; Q Chen; H J Donahue; C R Jacobs
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

Review 2.  Portal tract fibrogenesis in the liver.

Authors:  Giuliano Ramadori; Bernhard Saile
Journal:  Lab Invest       Date:  2004-02       Impact factor: 5.662

3.  Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice.

Authors:  Dionne Lorena; Ian A Darby; Alain-Pierre Gadeau; Laetitia Lam Shang Leen; Susan Rittling; Luís C Porto; Jean Rosenbaum; Alexis Desmoulière
Journal:  J Hepatol       Date:  2005-08-15       Impact factor: 25.083

4.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.

Authors:  Peter Fickert; Gernot Zollner; Andrea Fuchsbichler; Conny Stumptner; Andreas H Weiglein; Frank Lammert; Hanns-Ulrich Marschall; Oleksiy Tsybrovskyy; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

Review 5.  Inflammation and biliary tract injury.

Authors:  Brandy R Lu; Cara L Mack
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

6.  Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis.

Authors:  Kenichi Harada; Satoru Ozaki; Yoshiko Sudo; Koichi Tsuneyama; Hajime Ohta; Yasuni Nakanuma
Journal:  Pathol Int       Date:  2003-01       Impact factor: 2.534

Review 7.  Clinical features and management of primary sclerosing cholangitis.

Authors:  Marina-G Silveira; Keith-D Lindor
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 8.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

Review 9.  The role of cholangiocytes in the development of chronic inflammatory liver disease.

Authors:  David H Adams; Simon C Afford
Journal:  Front Biosci       Date:  2002-07-01

10.  Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.

Authors:  Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-25       Impact factor: 4.052

View more
  21 in total

1.  Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.

Authors:  Raquel Urtasun; Aritz Lopategi; Joseph George; Tung-Ming Leung; Yongke Lu; Xiaodong Wang; Xiaodong Ge; Maria Isabel Fiel; Natalia Nieto
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

2.  A preliminary in vivo study of the effects of OPN on rat liver regeneration induced by partial hepatectomy.

Authors:  Gaiping Wang; Congcong Zhao; Shasha Chen; Xiaofang Li; Ling Zhang; Cuifang Chang; Cunshuan Xu
Journal:  Mol Biol Rep       Date:  2016-09-01       Impact factor: 2.316

3.  Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.

Authors:  Yi Zhou; Meng Xu; Pin Liu; Binyong Liang; Manning Qian; Haichuan Wang; Xinhua Song; Pranavanand Nyshadham; Li Che; Diego F Calvisi; Feng Li; Shumei Lin; Xin Chen
Journal:  Am J Pathol       Date:  2020-04-07       Impact factor: 4.307

Review 4.  Animal models of biliary injury and altered bile acid metabolism.

Authors:  Valeria Mariotti; Mario Strazzabosco; Luca Fabris; Diego F Calvisi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-11       Impact factor: 5.187

5.  Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia.

Authors:  Paula M Hertel; Sue E Crawford; Milton J Finegold; Mary K Estes
Journal:  Virology       Date:  2011-07-13       Impact factor: 3.616

6.  Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.

Authors:  Sun-Jae Lee; Kyung-Hyun Kim; Sok Cheon Pak; Yu-Na Kang; Ghil-Suk Yoon; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin-proteasome system and oxidative stress.

Authors:  Fabián Campos; Johanna Abrigo; Francisco Aguirre; Bruno Garcés; Marco Arrese; Saul Karpen; Daniel Cabrera; Marcelo E Andía; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Pflugers Arch       Date:  2018-06-20       Impact factor: 3.657

8.  Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis.

Authors:  Juliane I Beier; J Phillip Kaiser; Luping Guo; Manuel Martínez-Maldonado; Gavin E Arteel
Journal:  Arch Biochem Biophys       Date:  2011-04-09       Impact factor: 4.013

9.  Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet.

Authors:  Michael D Thompson; Mary J Cismowski; Aaron J Trask; Scott W Lallier; Amanda E Graf; Lynette K Rogers; Pamela A Lucchesi; David R Brigstock
Journal:  Gene Expr       Date:  2016-06-23

Review 10.  Mechanisms of immune-mediated liver injury.

Authors:  David H Adams; Cynthia Ju; Shashi K Ramaiah; Jack Uetrecht; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2010-01-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.